Tesi et al. back $15m series-C for BC Platforms

Backers include Finnish VC investor Tesi, US-based corporate IQVIA and Swiss biopharmaceutical group Debiopharm. IQVIA was the lead investor in the round.

As part of its investment, IQVIA will have an appointee on the BC Platforms board of directors.

BC Platforms and IQVIA plan to collaborate on launching new data driven technologies that integrate complex clinical and genomic data to benefit research.

The company will use the fresh capital to expand its global network.

Previous Funding
In 2017, Tesi and Debiopharm invested in a $10m series-B funding round for BC Platforms.

Company
Founded in 1997 from an MIT Whitehead project spin-out, BC Platforms is a provider of genomic data management and analysis tools. The company has global operations with its headquarters in Zurich. It has 410 employees, according to Owler.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Technology
• DACH
• Switzerland
• Tesi
• Venture